Emergent Biosolutions EBS Total Cost of Revenue
Total Cost of Revenue at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Emergent Biosolutions in its filing.
Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.
The official record: Emergent Biosolutions’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →
Ask your AI about Emergent Biosolutions's total cost of revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Emergent Biosolutions's total cost of revenue?
- Emergent Biosolutions (EBS) reported total cost of revenue of $72M in Q1 2026.
- How has Emergent Biosolutions's total cost of revenue changed year-over-year?
- Emergent Biosolutions's total cost of revenue decreased by 18.6% year-over-year, from $88.5M to $72M.
- What is the long-term trend for Emergent Biosolutions's total cost of revenue?
- Over 3 years (2022 to 2025), Emergent Biosolutions's total cost of revenue has grown at a -22.2% compound annual growth rate (CAGR), from $693.4M to $326.2M.
- What does total cost of revenue mean?
- The aggregate of all direct costs attributable to producing goods and delivering services that generated the company's revenue, including materials, labor, and overhead.